James D McChesney

This inventor holds 58 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Cancer Treatment (CPC class A61K). Top assignees: Tapestry Pharmaceuticals, Inc., Napro Biotherapeutics, Inc., Arbor Therapeutics, LLC. Active years: 1990-2026.

USPTO Granted Patents = 58 (Patent Applications = 8)

% Patents Active = 70.7

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 172(Granted Patents)

Forward Citations (Not Self Cited) = 98(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Boulder, CO (US) (1999 - 2010)
Etta, MS (US) (1990 - 2024)

Company Filing History:

23 out of 23

Tapestry Pharmaceuticals, Inc.

patents

12 out of 33

Napro Biotherapeutics, Inc.

patents

6 out of 6

Arbor Therapeutics, LLC

patents

4. 3 out of 3

Ironstone Separations, Inc.

patents

5. 3 out of 25

Signpath Pharma, Inc.

patents

6. 3 out of 158

The University of Mississippi

patents

7. 3 out of 3

Veiled Therapeutics LLC

patents

8. 5 out of 834,411

Other

patents

Years Active: 1990-2026

Loading Chart...

Areas of Expertise:

Taxane Analogs

Cancer Chemotherapeutics

Lipophilic Prodrugs

Nanoparticulate Compositions

Biologically Active Compounds

Oral Administration

Chiral Resolution

Molecular Conjugates

Cardiopathy-Reducing Lipids

Aqueous Beverages

Chromatography Methods

Targeted Delivery

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734149 - Taxane analogs for the treatment of brain cancer (2026-09-15),

2. 12583865 - Biologically active taxane analogs and methods of treatment by oral administration (2026-03-24),

3. 11873308 - Biologically active taxane analogs and methods of treatment by oral administration (2024-01-16),

4. 11786504 - Taxane analogs for the treatment of brain cancer (2023-10-17),

5. 11746119 - Cardiopathy-reducing phosphodiester lipids (2023-09-05),

6. 11643424 - Cardiopathy-reducing phosphodiester lipids (2023-05-09),

7. 11220512 - Biologically active taxane analogs and methods of treatment by oral administration (2022-01-11),

8. 11147793 - Taxane analogs for the treatment of brain cancer (2021-10-19),

9. 10975111 - Cardiopathy-reducing phosphodiester lipids (2021-04-13),

10. 10745408 - Biologically active taxane analogs and methods of treatment by oral administration (2020-08-18),

11. 10703699 - Solubilization of pterostilbene and resveratrol for aqueous beverages (2020-07-07),

12. 10639293 - 9,10-α,α-OH-taxane analogs and methods for production thereof (2020-05-05),

13. 10450323 - Biologically active taxane analogs and methods of treatment by oral administration (2019-10-22),

14. 10369105 - Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation (2019-08-06),

15. 10238621 - 9,10-α,α-OH-taxane analogs and methods for production thereof (2019-03-26),

Title: James D McChesney: Pioneering Inventor in the Field of Medicine

Introduction:

James D McChesney, a dedicated inventor hailing from Etta, MS (US), is a true pioneer in the world of innovations. With a remarkable portfolio of 56 patents, his relentless pursuit of finding solutions to complex problems has made him a shining example for future generations of inventors.

Latest Patents:

McChesney's latest patents include groundbreaking inventions in the field of medicine. One of his notable patents is on "Biologically active taxane analogs and methods of treatment by oral administration," which focuses on a novel chemical compound for the treatment of cancer. Another significant patent is on "Taxane analogs for the treatment of brain cancer," highlighting compounds and methods for combating brain cancer in mammals.

Career Highlights:

Throughout his career, McChesney has made notable contributions to various companies in the pharmaceutical sector. He has worked with Tapestry Pharmaceuticals, Inc. and Napro Biotherapeutics, Inc., where his innovative mindset and problem-solving skills have led to groundbreaking advancements in medicine.

Collaborations:

McChesney has collaborated with esteemed coworkers such as Jan J Zygmunt and Gilles Hugues Tapolsky. Together, they have brought forth innovative ideas and technologies that have shaped the landscape of medical inventions.

Conclusion:

In conclusion, James D McChesney's dedication to innovation and his significant contributions to the field of medicine make him a true trailblazer. His work not only pushes the boundaries of what is possible but also inspires future inventors to think creatively and strive for excellence in their pursuits.